Dolutegravir O-β-D-Glucoside Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Dolutegravir O-β-D-Glucoside is a metabolite of Dolutegravir (D528800); a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.

Dolutegravir O-β-D-Glucoside Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Dolutegravir O-β-D-Glucoside Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
guoyungurui	18162595016; 18162595016	3287908757@qq.com	China	10335	58

---

• Dolutegravir O-β-D-Glucoside
• 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-7-(β-D-glucopyranosyloxy)-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-, (4R,12aS)-
• Unii-29LH9led64
• 1822365-49-0
• C26H29F2N3O10